» Articles » PMID: 37189711

Biological Role of Zinc in Liver Cirrhosis: An Updated Review

Overview
Journal Biomedicines
Date 2023 May 16
PMID 37189711
Authors
Affiliations
Soon will be listed here.
Abstract

Liver cirrhosis is a complication usually due to the consequence of persistent chronic liver disease. It is associated with different mechanisms, including hypoalbuminemia, impaired amino acid turnover, and micronutrient deficiencies. Consequently, cirrhotic patients can develop progressive complications like ascites, hepatic encephalopathy, and hepatocellular carcinoma. The liver is a vital organ that regulates the different metabolic pathways and transportation of trace elements. Zn is an indispensable micronutrient trace element involved in its crucial functions in cellular metabolic activity. Zn mediates its action by binding to a wide range of proteins; therefore, it imparts numerous biological effects, including cellular division, differentiation, and growth. It is also involved in critical processes for the biosynthesis of structural proteins and regulation of transcription factors and acts as a co-factor for the various enzymatic processes. As the liver is a significant regulator of Zn metabolism, its abnormalities lead to Zn deficiency, which has consequences on cellular, endocrine, immune, sensory, and skin dysfunctions. Conversely, Zn deficiency may modify the functions of hepatocytes and immune responses (acute phase protein production) in inflammatory liver diseases. This review has concisely stated the evolving indication of the critical role of Zn in biological processes and complications associated with liver cirrhosis pathogenesis due to Zn deficiency.

Citing Articles

Correlation of Serum Zinc Levels with Hepatic Encephalopathy Severity in Patients with Decompensated Liver Cirrhosis: A Prospective Observational Study from Egypt.

Semeya A, Elgamal R, Othman A Biol Trace Elem Res. 2025; .

PMID: 39946027 DOI: 10.1007/s12011-025-04544-x.


Trace element zinc metabolism and its relation to tumors.

Yao G, Wang Z, Xie R, Zhanghuang C, Yan B Front Endocrinol (Lausanne). 2024; 15:1457943.

PMID: 39717098 PMC: 11664221. DOI: 10.3389/fendo.2024.1457943.


Stem cell transplantation therapy for advanced liver damage-associated neurodegenerative disorders.

Sharma A, Sharma A, Dheer D, Sharma R, Puri V, Bibi S Int J Surg. 2024; 110(11):6873-6882.

PMID: 39699862 PMC: 11573053. DOI: 10.1097/JS9.0000000000002001.


The prevalence and risk factors associated with zinc deficiency after pancreatic surgery.

Nobori C, Matsumoto I, Nakano M, Ami K, Yoshida Y, Lee D Surg Today. 2024; .

PMID: 39222257 DOI: 10.1007/s00595-024-02935-6.


Optimising wound care for patients with cirrhosis: A study of the effect of combination therapy on wound healing.

Lin X, Su J, Yang Z Int Wound J. 2024; 21(2):e14727.

PMID: 38356305 PMC: 10867491. DOI: 10.1111/iwj.14727.


References
1.
Buchman A . Total parenteral nutrition: challenges and practice in the cirrhotic patient. Transplant Proc. 2006; 38(6):1659-63. DOI: 10.1016/j.transproceed.2006.05.030. View

2.
Jenne C, Kubes P . Immune surveillance by the liver. Nat Immunol. 2013; 14(10):996-1006. DOI: 10.1038/ni.2691. View

3.
Grungreiff K, Reinhold D, Wedemeyer H . The role of zinc in liver cirrhosis. Ann Hepatol. 2015; 15(1):7-16. DOI: 10.5604/16652681.1184191. View

4.
Hentze M, Muckenthaler M, Andrews N . Balancing acts: molecular control of mammalian iron metabolism. Cell. 2004; 117(3):285-97. DOI: 10.1016/s0092-8674(04)00343-5. View

5.
Riggio O, Ariosto F, Merli M, Caschera M, Zullo A, Balducci G . Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig Dis Sci. 1991; 36(9):1204-8. DOI: 10.1007/BF01307509. View